"BPC-157 is FDA approved now."
No. The reclassification changes the legal pathway, not the evidence. There are still only a handful of small human studies on it.
Knowing that difference is what separates a researcher from someone buying hype.
Which peptide myth do you see repeated the most?
🧪 GHK-Cu Stability Study
New Data is our Skool group on a study of reconstituted GHK-Cu stored for 3 months under two common laboratory conditions:
• 🌡️ Room Temperature (~70°F)
• ❄️ Refrigerated (~35°F)
Key Findings are posted in our Skool group. https://t.co/Lbbz04zVUP
We will be tracking the July ruling in real time and breaking down each compound as the list gets confirmed.
Follow @startmyresearch for the facts, not the hype.
Bookmark this thread for when the news hits.
Everyone in the peptide world is talking about the FDA reclassification. Most of what you are reading about it is wrong.
Here is what actually changed, what did not, and what July 23 really means.
Bookmark this.
If this passes, access shifts from gray market research chemical sites to physician prescriptions filled by licensed compounding pharmacies.
Verified potency, real sourcing standards, actual oversight. That is the part of the story that matters.
Most “lab tested” claims in the are unverifiable the moment you leave the manufacturer’s website. Our PureTrace™ Verification System changes the audit trail from a marketing asset into a tamper-evident record anyone can verify. Supply chain trust shouldn’t require blind faith. #PureTrace